Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Leukemia, Myeloid, Acute 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Myelodysplastic Syndromes 26Recurrence 18Multiple Myeloma 18Lymphoma, Non-Hodgkin 15Lymphoma, B-Cell 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma 14Ovarian Neoplasms 12Hematologic Neoplasms 12Pancreatic Neoplasms 10Melanoma 10Hodgkin Disease 10Myeloproliferative Disorders 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Leukemia 9Burkitt Lymphoma 9Stomach Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Neoplasms 7Lymphoma, Mantle-Cell 7Lymphoma, Follicular 7Leukemia, Biphenotypic, Acute 7Colorectal Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasm Metastasis 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Myelomonocytic, Chronic 6Breast Neoplasms 6

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gaucher Disease × fludarabine × 90 days × Clear all
NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
18 enrolled
CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡